Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

470 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The retinoblastoma protein pathway in cell cycle control and cancer.
Bartek J, Bartkova J, Lukas J. Bartek J, et al. Among authors: lukas j. Exp Cell Res. 1997 Nov 25;237(1):1-6. doi: 10.1006/excr.1997.3776. Exp Cell Res. 1997. PMID: 9417859 Review.
Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
Gjetting T, Lukas J, Bartek J, Strauss M. Gjetting T, et al. Among authors: lukas j. Biol Chem Hoppe Seyler. 1995 Jul;376(7):441-6. Biol Chem Hoppe Seyler. 1995. PMID: 7576242
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukas J, Aagaard L, Strauss M, Bartek J. Lukas J, et al. Cancer Res. 1995 Nov 1;55(21):4818-23. Cancer Res. 1995. PMID: 7585513
Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.
Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M, Bartek J. Aagaard L, et al. Among authors: lukas j. Int J Cancer. 1995 Mar 29;61(1):115-20. doi: 10.1002/ijc.2910610120. Int J Cancer. 1995. PMID: 7705923
Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Lukas J, et al. Mol Cell Biol. 1995 May;15(5):2600-11. doi: 10.1128/mcb.15.5.2600. Mol Cell Biol. 1995. PMID: 7739541 Free PMC article.
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Lukas J, et al. Nature. 1995 Jun 8;375(6531):503-6. doi: 10.1038/375503a0. Nature. 1995. PMID: 7777060
Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
Lukas J, Bartkova J, Welcker M, Petersen OW, Peters G, Strauss M, Bartek J. Lukas J, et al. Oncogene. 1995 Jun 1;10(11):2125-34. Oncogene. 1995. PMID: 7784057
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J. Bartkova J, et al. Among authors: lukas j. Cancer Res. 1995 Feb 15;55(4):949-56. Cancer Res. 1995. PMID: 7850812
Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.
Bartkova J, Lukas J, Strauss M, Bartek J. Bartkova J, et al. Among authors: lukas j. Oncogene. 1995 Feb 16;10(4):775-8. Oncogene. 1995. PMID: 7862456
BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Lukas J, Jadayel D, Bartkova J, Nacheva E, Dyer MJ, Strauss M, Bartek J. Lukas J, et al. Oncogene. 1994 Aug;9(8):2159-67. Oncogene. 1994. PMID: 8036001
470 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page